Fig. 2From: Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in AustriaEstimated cervical cancer incidence (related to types 16, 18, 6, 11, 31, 33, 45, 52, and 58) over 100Â yearsBack to article page